Sign in

CIK 0000908259

  • Non-accelerated filer
  • Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133679168
Phone
+1 650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
  1. 4 Grant or award Director acquired 35,000 shares (grant or award)
  2. 4 Grant or award Director acquired 35,000 shares (grant or award)
  3. 4 Grant or award Director acquired 43,662 shares (grant or award)
  4. 4 Grant or award Director acquired 42,017 shares (grant or award)
  5. 4 Grant or award Director acquired 42,017 shares (grant or award)
  6. 4 Grant or award Director acquired 30,000 shares (grant or award)
  7. 4 Grant or award Director acquired 30,000 shares (grant or award)
  8. 4 Grant or award Director acquired 30,000 shares (grant or award)
  9. 4 Grant or award Director acquired 30,000 shares (grant or award)
  10. 4 Grant or award Director acquired 30,000 shares (grant or award)
  11. 4 Grant or award Director acquired 30,000 shares (grant or award)
  12. 4 Grant or award Director acquired 4,049 shares (grant or award)
  13. 4 Grant or award Director acquired 5,369 shares (grant or award)
  14. 4 Grant or award Director acquired 3,169 shares (grant or award)
  15. 4 Grant or award Director acquired 16,002 shares (grant or award)
  16. 4 Grant or award Director acquired 14,022 shares (grant or award)
  17. 4 Grant or award Director acquired 20,061 shares (grant or award)
  18. 4 Grant or award Director acquired 16,780 shares (grant or award)
  19. 4 Other acquisition Director acquired 10,000,000 shares (other)
  20. 4 Option exercise Director acquired 11,281,877 shares (option exercise)

Page 9 of 17 · 325 filings